158 related articles for article (PubMed ID: 10325583)
1. Bioavailability of clobetasol propionate-quantification of drug concentrations in the stratum corneum by dermatopharmacokinetics using tape stripping.
Weigmann H; Lademann J; v Pelchrzim R; Sterry W; Hagemeister T; Molzahn R; Schaefer M; Lindscheid M; Schaefer H; Shah VP
Skin Pharmacol Appl Skin Physiol; 1999; 12(1-2):46-53. PubMed ID: 10325583
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of clobetasol propionate in different vehicles.
Franz TJ; Lehman PA; Feldman SR; Spellman MC
Skin Pharmacol Appl Skin Physiol; 2003; 16(4):212-6. PubMed ID: 12784060
[TBL] [Abstract][Full Text] [Related]
3. Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability.
Weigmann HJ; Lademann J; Schanzer S; Lindemann U; von Pelchrzim R; Schaefer H; Sterry W; Shah V
Skin Pharmacol Appl Skin Physiol; 2001; 14 Suppl 1():98-102. PubMed ID: 11509914
[TBL] [Abstract][Full Text] [Related]
4. Unexpected clobetasol propionate profile in human stratum corneum after topical application in vitro.
Mueller B; Anissimov YG; Roberts MS
Pharm Res; 2003 Nov; 20(11):1835-7. PubMed ID: 14661929
[TBL] [Abstract][Full Text] [Related]
5. Determination of the formation of the stratum corneum reservoir for two different corticosteroid formulations using tape stripping combined with UV/VIS spectroscopy.
Pelchrzim Rv; Weigmann HJ; Schaefer H; Hagemeister T; Linscheid M; Shah VP; Sterry W; Lademann J
J Dtsch Dermatol Ges; 2004 Nov; 2(11):914-9. PubMed ID: 16281609
[TBL] [Abstract][Full Text] [Related]
6. The lateral spread of clobetasol 17-propionate in the stratum corneum in vivo.
Ashworth J; Watson WS; Finlay AY
Br J Dermatol; 1988 Sep; 119(3):351-8. PubMed ID: 3179208
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical availability of clobetasol-17-propionate from cream and ointment.
Dyderski S; Grześkowiak E; Szałek E; Mrzygłód A
Acta Pol Pharm; 2001; 58(6):435-8. PubMed ID: 12197615
[TBL] [Abstract][Full Text] [Related]
8. Comparison of tape stripping with the human skin blanching assay for the bioequivalence assessment of topical clobetasol propionate formulations.
Au WL; Skinner M; Kanfer I
J Pharm Pharm Sci; 2010; 13(1):11-20. PubMed ID: 20456826
[TBL] [Abstract][Full Text] [Related]
9. In vitro penetration through the skin layers of topically applied glucocorticoids.
Carrer V; Alonso C; Oliver MA; Coderch L
Drug Test Anal; 2018 Oct; 10(10):1528-1535. PubMed ID: 29788546
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of topical application of clobetasol 17-propionate from various cream bases.
Fang JY; Shen KL; Huang YB; Wu PC; Tsai YH
Drug Dev Ind Pharm; 1999 Jan; 25(1):7-14. PubMed ID: 10028413
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Clobetasol Propionate Generics Using Simplified In vitro Bioequivalence Method for Topical Drug Products.
Soares KCC; de Souza WC; de S Texeira L; da Cunha-Filho MSS; Gelfuso GM; Gratieri T
Curr Drug Deliv; 2018; 15(7):998-1008. PubMed ID: 29165079
[TBL] [Abstract][Full Text] [Related]
12. 0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects.
Kerscher MJ; Korting HC; Mehringer L; Mätzig R
Skin Pharmacol; 1996; 9(2):120-3. PubMed ID: 8722606
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay.
Pershing LK; Silver BS; Krueger GG; Shah VP; Skelley JP
Pharm Res; 1992 Jan; 9(1):45-51. PubMed ID: 1589409
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of clobetasol spray: factors beyond patient compliance.
Bhutani T; Koo J; Maibach HI
J Dermatolog Treat; 2012 Feb; 23(1):11-5. PubMed ID: 21254848
[TBL] [Abstract][Full Text] [Related]
15. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
[TBL] [Abstract][Full Text] [Related]
16. 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.
Korting HC; Vieluf D; Kerscher M
Eur J Clin Pharmacol; 1992; 42(2):159-61. PubMed ID: 1618247
[TBL] [Abstract][Full Text] [Related]
17. The effect of the vehicle formulation on the stratum corneum penetration characteristics of clobetasol 17-propionate in vivo.
Watson WS; Finlay AY
Br J Dermatol; 1988 Apr; 118(4):523-30. PubMed ID: 3377973
[TBL] [Abstract][Full Text] [Related]
18. Relation of application time to bioactivity of a potent topical glucocorticoid formulation.
Stoughton RB; Wullich K
J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1038-41. PubMed ID: 2370328
[TBL] [Abstract][Full Text] [Related]
19. Elimination of ketoprofen from the stratum corneum after topical administration with ketoprofen formulations in human subjects.
Takeshi M; Ebihara T; Maekawa K; Yamamoto K; Higo N
Int J Pharm; 2014 Apr; 465(1-2):197-201. PubMed ID: 24530385
[TBL] [Abstract][Full Text] [Related]
20. Halobetasol Propionate Lotion, 0.05% Provides Superior Hydration Compared to Halobetasol Propionate Cream, 0.05% in a Double-Blinded Study of Occlusivity and Hydration.
Grove G; Zerweck C; Houser T; Andrasfay A; Gauthier B; Holland C; Piacquadio D
J Drugs Dermatol; 2017 Feb; 16(2):140-144. PubMed ID: 28300856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
